After a 3% rise this year, Unilever stock (NYSE: UL) is fully valued, in our view. Unilever
UL
Unilever sales can be clubbed into three segments – Personal Care, Food & Refreshments. and Home Care. The company’s revenue growth over the recent years has been driven by solid pricing growth. Total sales in 2022 grew 9%, led by 11% pricing growth, partly offset by a 2% decline in volume. The volume growth was 1.6% in 2021 and 2020, while the pricing growth was 2.9% in 2021 and 0.3% in 2020. As we look forward, the pricing growth will likely cool down in the near
near
Although the company’s sales have risen over the recent years, its underlying operating margin has consistently declined from 18.5% in 2020 to 16.1% in the last twelve months due to higher expenses, including a rise in input costs. The company’s bottom line decreased 8% y-o-y to Eur 2.37 in 2022, led by a 230 bps operating margin contraction. With costs expected to remain elevated and volume growth likely to be adversely impacted in a recession, Unilever is expected to see a decline in earnings in 2023, partly offset by share repurchases. Unilever has Eur 1.5 billion remaining in its current share buyback program for 2022-23.
Looking at valuation, we find that Unilever’s stock is fully valued. At its current level of $52, UL is trading at 2.2x its trailing twelve months’ revenues, compared to the last three-year average of 2.7x. We estimate Unilever’s Valuation to be $52 per share, aligning with the current market price, and represents a 2.2x P/S multiple based on TTM revenues. A slight decline in Unilever’s P/S multiple compared to its historical average makes sense, given the consistent decrease in operating margin and an expected hit on top and bottom-line growth in the near term.
While UL stock looks appropriately priced, it is helpful to see comparisons for companies across industries at Peer Comparisons.
Furthermore, the Covid-19 crisis has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised at how counter-intuitive the stock valuation is for F5 vs. Target
TGT
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates
Read the full article here